Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.ftc.gov/news-events/news/press-releases/2023/12/ftc-seeks-block-sanofis-acquisition-rare-disease-drug-threatens-sanofis-monopoly
0
0
FTC Seeks to Block Sanofi's Acquisition of Rare Disease Drug that Threatens Sanofi's Monopoly - Federal Trade Commission News
12/11/23 at 8:37pm
Organization
Ftc.gov
Authors
Details
49 words
Summarize
Business & Industrial
Sanofi
Acquisition of Rare Disease Drug
FTC
Monopoly - Federal Trade Commission News The Federal Trade Commission
Maze Therapeutics Inc.
The Federal Trade Commission is seeking to block Sanofi’s proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s therapy in development for treatment of Pompe disease.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...